Drug Discovery 2024: connecting minds, transforming science, empowering the community.
Europe’s largest conference for the drug discovery community returns to London, with scientific tracks covering not only therapeutic themes such as mechanisms of aging and cell & gene therapy but also more practical aspects of drug discovery encompassing advances in assay design, applications in high content imaging, target identification, and disease modeling. Whether you’re involved in early drug discovery research or translating your promising therapy to the clinic, you’ll be sure to discover something that can help you at this year’s event.
Our Head of R&D, Dylan Mooijman, will present a poster entitled, “Transcriptomic phenotyping of large-scale drug perturbation experiments”. The poster highlights our novel drug screening method, Discovery-seq. Discovery-seq combines molecular biology, high-throughput imaging, and data analysis to improve the limitations of current screening methods. Please visit our poster to learn more or meet us at booth C05!
If you would like to schedule a meeting with us, please do so via this link: Book a meeting